Healthcare provider profile · identity verified

Devon S Wojcikewych, MD

Internal Medicine · RICHMOND, VA · NPI 1912104209

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	323	99
Amlodipine Besylate	Amlodipine Besylate	189	67
Losartan Potassium	Losartan Potassium	148	49
Levothyroxine Sodium	Levothyroxine Sodium	128	40
Rosuvastatin Calcium	Rosuvastatin Calcium	97	44
Lisinopril	Lisinopril	84	25
Hydrochlorothiazide	Hydrochlorothiazide	80	28
Omeprazole	Omeprazole	80	35
Metoprolol Succinate	Metoprolol Succinate	68	23
Montelukast Sodium	Montelukast Sodium	68	25
Pravastatin Sodium	Pravastatin Sodium	67	20
Metformin Hcl Er	Metformin Hcl	65	28
Jardiance	Empagliflozin	64	21
Spironolactone	Spironolactone	59	20
Ezetimibe	Ezetimibe	46	15
Furosemide	Furosemide	44	18
Duloxetine Hcl	Duloxetine Hcl	43	15
Alendronate Sodium	Alendronate Sodium	41	17
Fluticasone Propionate	Fluticasone Propionate	41	14
Pantoprazole Sodium	Pantoprazole Sodium	41	11
Trulicity	Dulaglutide	41	suppressed
Chlorthalidone	Chlorthalidone	40	17
Gabapentin	Gabapentin	40	16
Ozempic	Semaglutide	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	17
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Trazodone Hcl	Trazodone Hcl	38	14
Escitalopram Oxalate	Escitalopram Oxalate	37	13
Famotidine	Famotidine	37	14
Irbesartan	Irbesartan	34	suppressed
Metformin Hcl	Metformin Hcl	34	16
Potassium Chloride	Potassium Chloride	34	14
Bupropion Xl	Bupropion Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	11
Simvastatin	Simvastatin	30	11
Clobetasol Propionate	Clobetasol Propionate	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Estradiol	Estradiol	26	14
Januvia	Sitagliptin Phosphate	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Eliquis	Apixaban	24	suppressed
Clonidine	Clonidine	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Sertraline Hcl	Sertraline Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Allopurinol	Allopurinol	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Atenolol	Atenolol	15	suppressed
Diazepam	Diazepam	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Torsemide	Torsemide	14	suppressed
Valsartan	Valsartan	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Temazepam	Temazepam	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Yuvafem	Estradiol	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Felodipine Er	Felodipine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error